Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Journal of Clinical Monitoring and Computing|August 24, 2017
The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantationTang Yunhua, Ju Weiqiang, Chen Maogen, et al.Spine|May 29, 2004
The role of collagen IX tryptophan polymorphisms in symptomatic intervertebral disc disease in Southern European patientsStefanos N Kales, Athena Linos, Christos Chatzis, et al.Frontiers in Pharmacology|July 1, 2024
Preclinical pharmacokinetic characterization of amdizalisib, a novel PI3Kδ inhibitor for the treatment of hematological malignanciesShuwen Jiang, Xiangkun Li, Weifang Xue, et al.Epidemiology (Cambridge, Mass.)|October 22, 2003
Genotyping patients with recent blood transfusionsMichelle Ng Gong, Yang Sai, Wei Zhou, et al.Cancer Chemotherapy and Pharmacology|May 13, 2014
Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor fruquintinib (HMPL-013) and the prediction of its human pharmacokineticsYi Gu, Jian Wang, Ke Li, et al.Current Drug Metabolism|May 15, 2020
Absorption, Metabolism and Excretion of Surufatinib in Rats and HumansKe Li, Sheng Ma, Liyan Miao, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 28, 2019
Preclinical pharmacokinetics, disposition, and translational pharmacokinetic/pharmacodynamic modeling of savolitinib, a novel selective cMet inhibitorYi Gu, Yang Sai, Jian Wang, et al.Fundamental & Clinical Pharmacology|October 27, 2022
Effect of a high-fat meal on the relative bioavailability of HMPL-689 in Chinese healthy volunteersWeie Cao, Qichen Ding, Yijun Wang, et al.Clinical Therapeutics|August 18, 2020
Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy SubjectsHongjie Qian, Xue Wu, Qian Chen, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 16, 2009
Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogsYi Gu, Guang-Ji Wang, Jian-Guo Sun, et al.Pageof 4